ArticleBlood cancer discoveryPublished
Preclinical characterization of the potent and selective MALT1 inhibitor safimaltib in B-cell lymphoma models
14 of 43 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Blood cancer discovery
- Published
- Topic
- Disease research
- PubMed ID
- 43002421
- Added to directory
- Source checked